NWPHF OTC
Newron Pharmaceuticals S.p.A.
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +0.0%
$20.00
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$64M
+147.1% ▲
5Y CAGR: +1.2%
Total Liabilities
$62M
+12.0% ▲
5Y CAGR: +21.6%
Shareholders Equity
$1M
+104.9% ▲
5Y CAGR: -47.6%
Cash & Investments
$10M
-22.0% ▼
5Y CAGR: -24.2%
Total Debt
$50M
+4.2% ▲
5Y CAGR: +24.5%
Net Debt
$44M
+3.5% ▲
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $13M | $25M | $13M | $6M | $7M |
| Short-Term Investments | $18M | $10M | $9M | $6M | $3M |
| Cash & ST Investments | $31M | $35M | $23M | $13M | $10M |
| Net Receivables | $7M | $1M | $2M | $3M | $42M |
| Inventory | $0 | $0 | $0 | $0 | $0 |
| Other Current Assets | $0 | $3M | $3M | $3M | $5M |
| Total Current Assets | $38M | $39M | $28M | $20M | $61M |
| Property, Plant & Equip. | $734K | $577K | $527K | $405K | $834K |
| Goodwill & Intangibles | $11K | $2K | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 |
| Other Non-Current Assets | -$745K | -$579K | -$527K | $6M | $2M |
| Total Non-Current Assets | $745K | $579K | $527K | $6M | $3M |
| Total Assets | $51M | $50M | $37M | $26M | $64M |
| — Liabilities — | |||||
| Accounts Payable | $1M | $2M | $2M | $2M | $2M |
| Short-Term Debt | $0 | $0 | $0 | $22M | $13M |
| Deferred Revenue | -$151K | -$150K | -$172K | $0 | $0 |
| Other Current Liabilities | $2M | $899K | $790K | $967K | $5M |
| Total Current Liabilities | $7M | $4M | $5M | $29M | $24M |
| Long-Term Debt | $26M | $43M | $45M | $26M | $36M |
| Other Non-Current Liab. | -$520K | -$389K | -$325K | $885K | $2M |
| Total Non-Current Liabilities | $26M | $43M | $45M | $27M | $39M |
| Total Liabilities | $34M | $47M | $51M | $56M | $62M |
| — Equity — | |||||
| Common Stock | $4M | $4M | $4M | $4M | $4M |
| Retained Earnings | -$26M | -$20M | -$23M | -$21M | $11M |
| Accumulated OCI | $14M | $15M | $5M | $0 | $0 |
| Total Stockholders Equity | $17M | $3M | -$14M | -$30M | $1M |
| Total Liabilities & Equity | $51M | $50M | $37M | $26M | $64M |
| — Key Metrics — | |||||
| Total Debt | $26M | $43M | $46M | $48M | $50M |
| Net Debt | $13M | $18M | $32M | $42M | $44M |
| Total Investments | $18M | $10M | $9M | $6M | $3M |